An affiliate of Balmoral Funds LLC has acquired Wilbur-Ellis Nutrition, LLC, a leading provider of custom nutrition solutions for the pet, aquaculture, and livestock markets. The company will now operate under the Rangen brand.
The deal includes Rangen, Ametza, Emmert, Oxy-Gon, Oxy-Gold, and Oxy-Block product lines, as well as proprietary premixes, ingredient blends, sourcing services, and all related operations. This transition positions Rangen as an independent platform with a strong foundation to expand its market presence and accelerate innovation.
Veteran executive Mark Essig has been appointed CEO of Rangen. With more than three decades of leadership experience in manufacturing, distribution, and specialty industries, Essig is known for building high-performing teams and delivering customer-focused results.
Balmoral Principal Richard Levernier added that the firm sees Rangen as well-positioned to invest in capacity expansion and product innovation while deepening relationships with customers, suppliers, and employees.
The acquisition underscores Balmoral’s strategy of supporting businesses with strong customer trust and growth potential, setting the stage for Rangen to capture emerging opportunities across the animal nutrition industry.
Blank Rome LLP served as legal counsel to Balmoral, while Wilbur-Ellis was advised by Lazard and Pillsbury Winthrop Shaw Pittman LLP.
Source: Business Wire
